• XXLP Targets NOX2/ROS/Mitochondria/NLRP3 Axis in Ulcerative

  2026-04-30

  Xu Chunfu’s Modified Xianglian Pill (XXLP) demonstrates targeted therapeutic action in a DSS-induced mouse model of ulcerative colitis by regulating the NOX2/ROS/mitochondria/NLRP3 signaling axis and reshaping gut microbiota. These mechanistic insights clarify XXLP’s anti-inflammatory effects and suggest new directions for integrative treatment approaches.

• Aprotinin (BPTI): Integrative Perspectives on Membrane Biome

  2026-04-29

  Explore the unique interface between aprotinin’s protease inhibition and red blood cell membrane biomechanics. This article offers an in-depth, evidence-driven analysis of bovine pancreatic trypsin inhibitor’s (BPTI) role in perioperative blood loss reduction and experimental assay optimization.

• GDC-0941: Precision PI3K Inhibitor for Cancer Cell Assays

  2026-04-29

  GDC-0941 empowers oncology research with robust, ATP-competitive PI3K/Akt pathway inhibition—delivering reliable results, even in trastuzumab-resistant and HER2-amplified cancer models. This guide details advanced workflows, protocol optimizations, and troubleshooting strategies to maximize the impact of GDC-0941 in cell-based and in vivo studies.

• Vitamin C as an Anticancer Agent: Protocols, Organoid Models

  2026-04-28

  Vitamin C (ascorbic acid) is propelling cancer and antiviral research into new territory by delivering reproducible, dose-dependent tumor inhibition and apoptosis induction in advanced models. This article translates cutting-edge organoid evidence and optimized workflows into actionable, troubleshooting-focused guidance for researchers leveraging high-purity APExBIO Vitamin C (CAS 50-81-7).

• MK-1775 (Wee1 Kinase Inhibitor): Precision for p53-Deficient

  2026-04-28

  MK-1775 (Wee1 kinase inhibitor) from APExBIO is redefining cell cycle checkpoint research in p53-deficient tumor models. This guide translates advanced in vitro findings into actionable protocols, troubleshooting advice, and comparative insights for DNA damage response assays.

• MLKL Polymerization Drives Lysosomal Permeabilization in Nec

  2026-04-27

  This study uncovers how polymerized MLKL directly induces lysosomal membrane permeabilization (LMP), preceding plasma membrane rupture and driving necroptotic cell death. The findings clarify the sequence and mechanisms of organelle disruption in necroptosis, establishing cathepsin B as a critical effector and revealing new intervention points for cell death modulation.

• Primidone (Mysoline): Advanced Workflows in ALS & TRPM3 Rese

  2026-04-27

  Primidone (Mysoline) empowers translational neurobiology research by uniquely combining potent RIPK1 and TRPM3 inhibition with a favorable selectivity profile. Explore optimized workflows, animal model data, and troubleshooting strategies that leverage APExBIO's research-grade Primidone for reproducible, high-impact results.

• CD28-ARS2-Mediated PKM Splicing Drives CD8+ T Cell Flexibili

  2026-04-26

  The referenced study uncovers how the CD28-ARS2 axis orchestrates alternative splicing of pyruvate kinase M (PKM), enabling metabolic adaptability in CD8+ T cells and bolstering antitumor immunity. These findings not only clarify the molecular basis of T cell immunometabolic plasticity, but also suggest new avenues for investigating metabolic enzyme regulation under immune activation.

• Aminopeptidase Inhibition Modulates Angiotensin Signaling in

  2026-04-25

  Harding and Felix (1987) demonstrated that Bestatin hydrochloride enhances angiotensin II and III-evoked neuronal activity in the rat brain by inhibiting aminopeptidase B. Their findings clarify the enzymatic conversion of angiotensin II to III as a prerequisite for neural activation, and provide critical insight for research on neuropeptide regulation and enzymatic targeting.

• Ordered DNA Nanostructures Enhance Enzymatic DNA Synthesis E

  2026-04-24

  This study introduces a highly ordered tetrahedral DNA framework to address spatial hindrance and improve efficiency in enzymatic oligonucleotide synthesis (EOS). The approach significantly enhances enzyme accessibility and fidelity, supporting longer DNA synthesis and enabling accurate nucleic acid applications, such as DNA data storage.

• Protoporphyrin IX: Photodynamic Compound in Ferroptosis and

  2026-04-24

  Explore the dual role of Protoporphyrin IX as a photodynamic compound in cancer research and its central function in ferroptosis and heme formation. This article uniquely connects advanced mechanistic insights from recent hepatocellular carcinoma studies to practical laboratory applications.

• Q-VD(OMe)-OPh: Precision Caspase Inhibition for Apoptosis Re

  2026-04-23

  Q-VD(OMe)-OPh (quinolyl-valyl-O-methylaspartyl-[-2,6-difluorophenoxy]-methyl ketone) delivers potent, broad-spectrum caspase inhibition with minimal toxicity, setting a new benchmark for apoptosis and cell death assays. Its versatility and reproducibility empower researchers in cancer, neuroprotection, and mechanistic apoptosis studies.

• Topotecan (SKF104864): Precision Topoisomerase I Inhibition

  2026-04-23

  Topotecan (SKF104864) is a semi-synthetic camptothecin derivative that acts as a potent topoisomerase I inhibitor. It demonstrates broad-spectrum antitumor activity, including efficacy in recurrent small cell lung cancer (SCLC) and pediatric solid tumor models. Its mechanism and predictable toxicity profile make Topotecan a cornerstone tool in translational cancer research.

• Polymyxin B Sulfate: Precision Tool for Gram-Negative Infect

  2026-04-22

  Polymyxin B sulfate delivers reproducible, high-impact results in multidrug-resistant Gram-negative infection and immune modulation studies. This guide provides workflow-driven protocols, optimization strategies, and troubleshooting insights, leveraging APExBIO's rigorously benchmarked formulation.

• 6-Thioguanine Suppresses EV71 via BIRC3-Mediated Autophagy I

  2026-04-22

  This study demonstrates that 6-thioguanine (6-TG) significantly inhibits EV71 replication in vitro by targeting BIRC3-mediated autophagy in human intestinal cells. The findings highlight a novel antiviral mechanism for 6-TG, suggesting translational potential for enteroviral therapeutics and providing a foundation for further mechanistic and preclinical research.

15211 records 1/1015 page Next 12345 下5页 Last page